Staar Sets Sights On ICL Approval, Awaits Swiss, U.S. Facility Inspections
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical expects to launch the Visian ICL intraocular lens at the American Academy of Ophthalmology's October annual meeting, barring further approval setbacks resulting from FDA inspections
You may also be interested in...
Staar Compliance Effort Exempt From Belt Tightening; Merger Among Options
Staar Surgical will seek to raise $8 mil.-$10 mil. from existing investors to shore up its cash position while it considers strategic alternatives, including a possible sale of the company, the firm says
Staar Compliance Effort Exempt From Belt Tightening; Merger Among Options
Staar Surgical will seek to raise $8 mil.-$10 mil. from existing investors to shore up its cash position while it considers strategic alternatives, including a possible sale of the company, the firm says
AMO To Surround Eye Surgeons With Refractive Offerings After Visx Purchase
Advanced Medical Optics' acquisition of pure-play LASIK manufacturer Visx will enable the combined entity to more effectively market laser eye surgery to physicians performing both refractive and cataract procedures